Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

NCT01361646 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT01361646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01361646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189
Lead sponsor
LG Life Sciences
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2011
Completion date
January 31, 2013
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gout, hyperuricemia